US FDA Is Pulled Into Zofran Product Liability Litigation

 
• By Brenda Sandburg

Agency officials meet with GSK and plaintiffs' steering committee in wake of GSK citizen petition; judge asks FDA to resolve petition 'expeditiously' as it could impact resolution of preemption dispute and the outcome of the litigation alleging Zofran caused birth defects.

Building icon with inscription FDA.
FDA's response to citizen petition could determine the outcome of Zofran product liability litigation.

More from US FDA

More from Agency Leadership